MedTrace Logo

A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis

NCT00584597 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2010-12-13

No results posted yet for this study

Summary

The specific aim of this study will be to determine the safety of TRAUMEEL S for mucositis in head and neck cancer patients undergoing radiation therapy.

Conditions

Interventions

DRUG

Saline

Saline Control

DRUG

Traumeel S

Traumeel S 1 mL

DRUG

Traumeel S

Traumeel S 2mL

DRUG

Traumeel S

Traumeel S 3mL

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Greg Krempl, MD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00584597 on ClinicalTrials.gov